913181-90-5 Usage
General Description
The chemical [2-(4-Bromo-phenyl)-2-hydroxy-ethyl]-carbamic acid tert-butyl ester is a compound with the molecular formula C12H17BrNO3. It is a tert-butyl ester derivative of carbamic acid, and it contains a bromo-phenyl group and a hydroxy-ethyl group. This chemical is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various organic compounds. It has potential applications in the production of drugs and other pharmaceutical products. The specific properties and uses of this compound may vary depending on the context in which it is being utilized.
Check Digit Verification of cas no
The CAS Registry Mumber 913181-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,3,1,8 and 1 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 913181-90:
(8*9)+(7*1)+(6*3)+(5*1)+(4*8)+(3*1)+(2*9)+(1*0)=155
155 % 10 = 5
So 913181-90-5 is a valid CAS Registry Number.
InChI:InChI=1S/C13H18BrNO3/c1-13(2,3)18-12(17)15-8-11(16)9-4-6-10(14)7-5-9/h4-7,11,16H,8H2,1-3H3,(H,15,17)
913181-90-5Relevant articles and documents
Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy
Dong, Chengyuan,Liu, Fusheng,Shen, Youqing,Xiang, Jiajia,Zhou, Quan,Zhou, Zhuxian
, p. 529 - 539 (2020/03/04)
Amphiphilic drug conjugates can self-assemble into nanovehicles for cancer drug delivery, but the key is to design stable yet intracellular labile drug linkers for drug retention during blood circulation but fast intracellular drug release. The conjugatio
Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa
Lazarova, Tsvetelina I.,Jin, Lei,Rynkiewicz, Michael,Gorga, Joan C.,Bibbins, Frank,Meyers, Harold V.,Babine, Robert,Strickler, James
, p. 5022 - 5027 (2007/10/03)
A series of functionalized aryl boronic acids were synthesized and evaluated as potential inhibitors of factor XIa. Crystal structures of the protein-inhibitor complexes led to the design and synthesis of second generation compounds showing single digit m